Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 3 March 2022, 18:29 HKT/SGT
Share:
Yeahka Donate 60,000 Antigen Rapid Test Kits Supporting Hong Kong's Fight Against COVID-19

HONG KONG, Mar 3, 2022 - (ACN Newswire) - Yeahka Limited ("Yeahka" or the "Company") (09923.HK) has announced a donation of 60,000 antigen rapid test kits to support Hong Kong's fight against the increasingly serious outbreak of Covid-19.

The antigen rapid test kits will be donated to Po Leung Kuk and distributed to the elderly and disabled through its elderly service units and rehabilitation service units respectively, helping them monitor their health status in real-time.

The fifth wave of the pandemic has proven challenging for Hong Kong, with the number of new daily COVID-19 infections hitting record highs. In the face of the severe pandemic situation, there is an increase in demand for pandemic prevention resources. Yeahka has been closely monitoring the pandemic situation in Hong Kong and hopes the initiative will help, sending love and care to the people in need.

About YEAHKA LIMITED (Stock Code: 9923.HK)
Yeahka, listed on the Main Board of Hong Kong Stock Exchange in 2020, is a leading payment-based technology platform dedicated to creating value for merchants and consumers by providing one-stop payment services and diversified technology-enabled business services. According to Analysys's report in 2022, Yeahka ranks No.1 in the non-bank, Independent QR code payment service market in China.



Topic: Press release summary Sectors: Cards & Payments, Enterprise IT
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
Doubleview Gold Clarifies Preliminary Economic Assessment Results for the Hat Project; Updated Scenario B NPV Increased to C$7.27 Billion  
Mar 24, 2026 04:59 HKT/SGT
OMP Positioned Highest for Both Completeness of Vision and Ability to Execute in the 2026 Gartner(R) Magic Quadrant(TM) for Supply Chain Planning Solutions: Process Industries  
Mar 23, 2026 23:15 HKT/SGT
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders  
Mar 23, 2026 21:05 HKT/SGT
Essex Bio-Technology Reports Robust Results for FY2025, Turnover Soars 8.6% to HK$1814 million, Net Profit up 3.5% to HK$ 318.1 million, Total Dividend Increases by 16.7% to HK14 Cents per Share  
Mar 23, 2026 20:51 HKT/SGT
GMG Launches European Sales Team; G(R) Lubricant Patent Accepted for Europe  
Mar 23, 2026 20:29 HKT/SGT
Everest Medicines Enters into Asset Purchase Agreement for Etripamil Nasal Spray, Expanding Cardiovascular Footprint  
Mar 23, 2026 18:59 HKT/SGT
From SGD to Global Spending: How Singaporeans Can Avoid FX Fees While Travelling Overseas  
Mar 23, 2026 14:15 HKT/SGT
Fujitsu-developed traffic simulation system utilized in Maebashi City's public transportation planning  
Monday, March 23, 2026 1:24:00 PM
Hitachi Receives the 2026 Catalyst Award, a Global Recognition for Building an Inclusive Organization   
Monday, March 23, 2026 10:49:00 AM
Results from Real-World, Long-Term Treatment Persistence with LEQEMBI(R) (lecanemab-irmb) in the United States Presented at AD/PD(TM) 2026  
Monday, March 23, 2026 10:19:00 AM
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: